Protein kinase C (PKC) has been implicated in the mechanism of exocytosis, although various studies have been unable to pinpoint actual translocation or activation of PKC during exocytosis. We have studied, in neurohypophysial nerve endings, intracellular Ca2+ levels, secretion of neuropeptides and PKC translocation. Neurohormone secretion was triggered by K+-induced or electrically induced depolarization in both the absence and the presence of phorbol esters. PKC was translocated from the cytosol to the membrane on electrical stimulation or K+ depolarization, but not to the extent obtained with phorbol ester. Data are presented clearly demonstrating that the translocation of PKC from cytosol to membrane is not required for exocytosis, nor does it alter in any way neuropeptide release from neurohypophysial nerve terminals.
INTRODUCTION
In response to electrical stimulation or K+-induced depolarization, neurohypophysial nerve terminals release vasopressin (VP) and oxytocin (OT) via Ca2+-dependent exocytosis (for review see ref. [1] ). Considerable interest has been generated concerning the involvement of protein kinase C (PKC) in the process of exocytosis in a variety of systems [2] [3] [4] [5] [6] [7] [8] [9] [10] . Facilitation of exocytosis by phorbol esters or by diacylglycerol (DAG), the endogenous activator of PKC, apparently constitutes major evidence implicating a role for PKC in the mechanism of exocytosis. However, the phosphorylation of a putative specific PKC substrate during exocytosis under the influence of phorbol esters has been demonstrated only in a few instances [8] [9] [10] . PKC is translocated from the cytosol to the membrane [11] , and thus the enhanced association of the enzyme with the membrane leads to its activation. Unfortunately, information about the translocation/activation of PKC in studies of the effect of enzyme activators on exocytosis is scanty. The present study examines the influence of activators and inhibitors of PKC on exocytosis in neurohypophysial nerve endings containing peptidergic granules. This excitable tissue offers the possibility to study exocytosis in the absence of synthesis and axonal transport of secretory granules. We provide evidence that PKC is translocated from the cytosol to a membrane compartment in response to either electrical stimulation or K+-induced depolarization, but such translocation/activation is not required for, nor does it apparently modify, neuropeptide release from neurohypophysial nerve terminals.
MATERIALS AND METHODS

Isolation of neurosecretory nerve terminals
Neurosecretory nerve terminals were isolated from SpragueDawley (200-250 g) rats as described in ref. [12] Briefly, the pars intermedia was carefully removed and the neural lobe was homogenized in a medium containing 270 mM-sucrose, 10 /tM-EGTA, 1 mM-phenylmethanesulphonyl fluoride, 1 mm-benzamidine and 10 mM-Hepes, adjusted to pH 7.2 with Tris. After centrifugation in an Eppendorf micro-centrifuge for 1.5 min, the pellet was resuspended in 0.5 ml of physiological saline, containing 135 mM-NaCl, 5 mM-KCl, 1 mM-MgCl2, 2.2 mM-CaCl2, 10 mM-glucose and 10 mM-Hepes, pH 7.2. The operation was carried out at 37 'C.
Measurement of Ca2' in nerve terminals
The nerve endings were incubated for 30 min at 37 'C with 3 gM-fura-2/AM. After centrifugation for 30 s, the nerve endings were resuspended in the physiological saline. The intracellular Ca2+ concentration ([Ca2+] i) in individual nerve endings was determined by dual-wavelength microspectrofluorimetry using fura-2. All measurements were performed at 37 'C in a chamber providing rapid exchange of the superfusing physiological saline. Solutions in which [K+] was elevated were kept iso-osmotic by a similar decrease in Na+; a decrease in Na+ alone (N-methyl-Dglucamine replacement) had no effect on [Ca2+]i. A Nikon Diaphot inverted microscope equipped with a x 40 oil-immersion epifluorescence lens was used to select a single nerve ending which was then optically masked by using a pinhole diaphragm stopped down to a diameter of 5 ,im. The microscope was interfaced to a Spex Fluorolog spectrofluorimeter system, which generated alternating excitation wavelengths of 340 and 380 nm and which was used for collection and analysis of the emitted (510+20 nm) photon counts. Autofluorescence was determined on unloaded endings and subtracted from the signal at each wavelength before calculation of the F340/F380 ratio and conversion into [Ca2+]1. The fluorescence ratio was converted into [Ca2+] using the equation of Grynkiewicz et al. [13] .
Measurement of VP or OT release from K+-depolarized nerve terminals and from electrically stimulated neurohypophyses
The isolated neurosecretory nerve endings were prepared as described above, except that the pellet from the first 1 min centrifugation at 100g was discarded. The nerve endings were loaded on to an ACRO LC13 0.45 ,um-pore-size Gelman filter and perfused with physiological saline as described previously Vol. 273
Abbreviations used: PMA, phorbol 12-myristate 13- 9 and 1O %. The saline was similar to that described above, except that it contained 40 mM-NaCl and the osmolarity was maintained with N-methyl-D-glucamine. The isolated neural lobes were impaled on platinum electrodes and stimulated either at 4 Hz (2 ms, 3 mA, biphasic pulses) for 2 min, or with four bursts separated by 21 s intervals (for details see ref. [14] ). The pattern of the pulses in a burst was the exact image of that recorded in vivo from a cell in the hypothalamus of a dehydrated rat, a situation during which VP release is highly potentiated. The neural lobes were first stimulated electrically with four 'VP-like' bursts separated by 21 s intervals. The amount of hormone release during this period of time (S1) was calculated by subtracting the amount of hormone released under basal conditions from that observed during and after the stimulus. After a period of rest (50-60 min) the neural lobes were stimulated a second time, but in the presence (or absence, control experiments) of PKC activators or inhibitors. The amount of hormone release during this second period was called S2. After electrical stimulation of the neural lobe, the nerve endings were prepared as described above. They were rapidly homogenized in Tris/ EDTA medium for PKC determination. The time between the end of electrical stimulation and extraction of PKC was approx.
4 min.
PKC determinations in cytosolic and particulate fractions
The nerve endings were homogenized in a medium containing 2 mM-EDTA and 20 mM-Tris/HCl, pH 7.5; 0.2 mM-phenylmethanesulphonyl fluoride, 5 /tg of aprotinin/ml and 5,ug of pepstatin A/ml were added during homogenization. The homogenate was centrifuged at 100000 g for 20 min. The supernatant constituted the cytosolic fraction. The resulting pellet was suspended in an appropriate amount of a medium containing 2 mM-EDTA, 20 mM-Tris/HCl, pH 7.5, and 0.5 % Triton X-100, and sonicated for 3 x 5 s with I min intervals between each sonication, and then re-centrifuged at 100000 g for 20 min. The resulting supernatant was the particulate fraction. Under our conditions, 0.05 % Triton X-100 plus sonication was sufficient to extract particulate PKC activity. This was confirmed by using 0.1 0% or 0.2 % Triton X-l00; the PKC activity was not different from that recovered using 0.05 % Triton X-100 plus sonication. PKC activity in both cytosolic and particulate fractions was determined by histone (type III-S; Sigma) phosphorylation, as described in [15] . The standard assay medium (100 1) contained 20 mM-Tris/HCI, pH 7.5, 5 mM-MgC12, 1 mM-EGTA, 1 .75 mmCaCI2, 2 mM-phenylmethanesulphonyl fluoride, 16.6 ,ug of phosphatidylserine, 20,g of lysine-rich histone and 20 ,tM-ATP {approx. (3) (4) (5) Interestingly, H7, an inhibitor of PKC activity, had no effect on the translocation of PKC in either the presence or the absence of PMA. The ratio of particulate/cytosolic PKC activity was for PMA-treated nerve endings 1.60 + 0.19 (n = 4), and for nerve endings incubated in the presence of both PMA (100 nM) and H7 (100 #M) it was 2.09 + 0.44 (n = 4). H7 also had no effect on PKC activity measured after stimulation of the nerve endings with 100 mM-K+ or with the calcium ionophore A23187 (5/M), i.e. during enhanced peptide secretion. It must be pointed out that we used different batches of inhibitor, the potency of which was checked in a system in vitro. Fig. 1 Table 2   Table 3 . Effects of PKC inhibitors on VP release Neural lobes were stimulated electrically with four VP bursts with 21 s resting intervals. In the case of stimulation induced by 100 mM-K+, two periods of 8 min were used, separated by a 60 min resting period as described in the Materials and methods section. PKC inhibitors were present 10 min before and during the second stimulation of VP secretion. For the Ca2" challenge experiments, isolated nerve endings were permeabilized with digitonin and challenged subsequently with 10 /tM-Ca2" (see ref. [20] ). *The results are expressed as quantity (ng) of VP released during the Ca2" challenge. Under control conditions, the VP release obtained in the two experiments was 1.11 ng and 1.16 ng. Values in other experiments represent the ratios of VP released during the second stimulation (S2) to the amount secreted during the first stimulus (S1). The results are given as means + S.E.M. of the numbers of experiments in parentheses.
Conditions
VP release (S2/S1) (2) 1.02 ±0.08 (3) 1.18+0.20 (3) 1.14 (2)* 1.13 + 0.02 (3)* lists the effects of PMA on VP release induced by 35 mM-K' in isolated nerve endings or by electrical stimulation of neural lobes. In none of the experiments did PMA potentiate the secretion of VP. It should be pointed out that the electrical stimulation that we have used imitates that of the magnocellular neurons recorded in vivo. The neurohypophyses were stimulated either with low frequency (4 Hz) or with a burst pattern which imitates that of the activity of VP secretory cells recorded in vivo in dehydrated animals, i.e. a physiological condition which induces an increase in VP secretion (for review see ref. [17] ). The amount of OT release from isolated terminals induced by 35 mm-K+ was also not modified in the presence of PMA (results not shown). In other experiments DAG (100 uM) had no effect on VP release from isolated nerve terminals stimulated with four bursts of pulses separated by resting periods. The S2/S1 ratio for controls was 0.79+0.14 (n = 8) and for DAG-treated nerve endings it was 0.73 +0.16 (n = 7). Thus PMA and DAG had no effect on basal release or on stimulated secretion of neuropeptides, although translocation of PKC (Table 1) was stimulated. Table 3 shows the results of experiments using inhibitors of PKC activity. H7 or staurosporine had no effect on VP release induced either by electrical stimulation of neural lobes or by depolarization of isolated neurosecretory nerve endings with K+. In another series of experiments we studied VP release from digitonin-permeabilized nerve endings [18] incubated in the presence of PKC-(19-36), a synthetic inhibitor of PKC activity [19] . No [20] , phorbol ester potentiates the secretion of OT and VP induced by low-frequency (4 Hz), but not by higher-frequency (20 Hz), electrical stimulation, with the potentiation of OT secretion being considerably greater than that for VP. On the other hand, Racke et al. [21] reported that both OT and VP releases were augmented, although to different extents, by phorbol ester treatment, and also occurred at both low-(3 Hz) and high-(15 Hz) frequency stimulation. In addition, although the former study [20] advances an argument for strong OT release by activation of PKC, the other [21] In conclusion, we have strong evidence to suggest that exocytosis in neurohypophysial nerve terminals is not directly mediated by PKC activation. This is in accord with the data favouring the occurrence of exocytosis independent of PKC activation in a variety of systems, including luteinizing-hormone release from pituitary gonadotropes [23] , secretion of interleukin-2 in lymphocytes [24] , and insulin secretion from permeabilized RIN m5F cells challenged with GTP analogues in the absence of Ca2+ [10] .
